Literature DB >> 373904

Cancer chemotherapy as it approaches middle age.

S K Carter.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 373904     DOI： 10.1007/bf00253140

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

1.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

2.  Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.

Authors:  S M Sieber; R H Adamson
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

Review 3.  Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.

Authors:  S K Carter
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

4.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245
  4 in total
  3 in total

1.  The clinical evaluation of analogues. I. The overall problem.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

Review 3.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.